Monday, October 24, 2016

Famciclovir




In the US, Famciclovir (famciclovir systemic) is a member of the drug class purine nucleosides and is used to treat Cold Sores, Herpes Simplex - Mucocutaneous/Immunocompetent Host, Herpes Simplex - Mucocutaneous/Immunocompromised Host, Herpes Simplex - Suppression and Herpes Zoster.

US matches:

  • Famciclovir

UK matches:

  • Famciclovir 125mg, 250mg, 500mg, 750mg Film-coated Tablets
  • Famciclovir 125mg, 250mg, 500mg, 750mg Tablets
  • Famciclovir 125 mg film-coated tablets (SPC)
  • Famciclovir 250 mg film-coated tablets (SPC)
  • Famciclovir 750 mg film-coated tablets (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AB09,S01AD07

CAS registry number (Chemical Abstracts Service)

0104227-87-4

Chemical Formula

C14-H19-N5-O4

Molecular Weight

321

Therapeutic Category

Antiviral agent

Chemical Name

2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate (ester)

Foreign Names

  • Famciclovirum (Latin)
  • Famciclovir (German)
  • Famciclovir (French)
  • Famciclovir (Spanish)

Generic Names

  • Famciclovir (OS: DCF, USAN, BAN)
  • AV 42810 (IS)
  • BRL 42810 (IS: Beecham)

Brand Names

  • Ancivin
    Padro, Spain


  • Apo-Famciclovir
    Apotex, Canada


  • CO Famciclovir
    Cobalt, Canada


  • Famciclovir Teva
    Teva, Spain; Teva, Ireland


  • Famciclovir
    Teva, Latvia; Teva USA, United States


  • Famtrex
    Cipla, India


  • Famvir Zoster
    Novartis, Luxembourg


  • Famvir
    GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Iran; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Qatar; GlaxoSmithKline, Romania; Novartis, Austria; Novartis, Australia; Novartis, Bulgaria; Novartis, Bahrain; Novartis, Canada; Novartis, Switzerland; Novartis, Czech Republic; Novartis, Germany; Novartis, Denmark; Novartis, Estonia; Novartis, Spain; Novartis, Finland; Novartis, United Kingdom; Novartis, Greece; Novartis, Hong Kong; Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Italy; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Latvia; Novartis, Malta; Novartis, Netherlands; Novartis, Oman; Novartis, Poland; Novartis, Russian Federation; Novartis, Sweden; Novartis, Singapore; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis, South Africa


  • Lizhufeng
    Livzon Zhuhai, China


  • Oravir
    Novartis, France


  • Pentavir
    Fortbenton, Argentina


  • PMS-Famciclovir
    Pharmascience, Canada


  • Sandoz Famciclovir
    Sandoz, Canada


  • Ziravir
    LPB, Italy

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment